Birnam Oak Advisors’s Verona Pharma VRNA Stock Holding History

Birnam Oak Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-277,604	Closed	-$29.6M	–	41
2025 Q3	$29.6M	Buy	+277,604	New	+$29M	6.8%	5

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Birnam Oak Advisors's VRNA Position: Q4 2025 in Review

Birnam Oak Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 277,604 shares — an estimated $29.6M sold.

Birnam Oak Advisors first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $29.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Birnam Oak Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Birnam Oak Advisors sold 277,604 Verona Pharma shares in Q4 2025, an estimated $29.6M.
Birnam Oak Advisors first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Birnam Oak Advisors's Verona Pharma position peaked at $29.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Birnam Oak Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.